118 related articles for article (PubMed ID: 37779228)
1. Causes of mortality among adults with Down syndrome before and after the COVID-19 pandemic in Spain.
Sánchez Moreno B; Adán-Lirola L; Rubio-Serrano J; Real de Asúa D
J Intellect Disabil Res; 2024 Feb; 68(2):128-139. PubMed ID: 37779228
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
Fortea J; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernández S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Alcolea D; Clarimón J; Zaman SH; Blesa R; Lleó A
Lancet; 2020 Jun; 395(10242):1988-1997. PubMed ID: 32593336
[TBL] [Abstract][Full Text] [Related]
3. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Causes of Death Collaborators
Lancet; 2024 May; 403(10440):2100-2132. PubMed ID: 38582094
[TBL] [Abstract][Full Text] [Related]
4. Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
Illouz T; Biragyn A; Frenkel-Morgenstern M; Weissberg O; Gorohovski A; Merzon E; Green I; Iulita F; Flores-Aguilar L; Dierssen M; De Toma I; Lifshitz H; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; Sarid R; London J; Mobley W; Strydom A; Okun E
Neuromolecular Med; 2021 Dec; 23(4):561-571. PubMed ID: 33660221
[TBL] [Abstract][Full Text] [Related]
5. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Demographics Collaborators
Lancet; 2024 May; 403(10440):1989-2056. PubMed ID: 38484753
[TBL] [Abstract][Full Text] [Related]
6. Unexplained mortality during the US COVID-19 pandemic: retrospective analysis of death certificate data and critical assessment of excess death calculations.
Fairman KA; Goodlet KJ; Rucker JD; Zawadzki RS
BMJ Open; 2021 Nov; 11(11):e050361. PubMed ID: 34785551
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility to COVID-19 Diagnosis in People with Down Syndrome Compared to the General Population: Matched-Cohort Study Using Primary Care Electronic Records in the UK.
Baksh RA; Strydom A; Pape SE; Chan LF; Gulliford MC
J Gen Intern Med; 2022 Jun; 37(8):2009-2015. PubMed ID: 35386043
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of the COVID-19 pandemic on the all-cause, cause-specific mortality, YLL, and life expectancy in the first 2 years in an Iranian population-an ecological study.
Pirayesh Z; Riahi SM; Bidokhti A; Kazemi T
Front Public Health; 2023; 11():1259202. PubMed ID: 37927873
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of individuals with Down syndrome deceased with CoVID-19 in Italy-A case series.
Villani ER; Carfì A; Di Paola A; Palmieri L; Donfrancesco C; Lo Noce C; Taruscio D; Meli P; Salerno P; Kodra Y; Pricci F; Tamburo de Bella M; Floridia M; Onder G;
Am J Med Genet A; 2020 Dec; 182(12):2964-2970. PubMed ID: 32918520
[TBL] [Abstract][Full Text] [Related]
10. COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort stuJune 2020.dy in Southern Catalonia, Spain, March-.
Vila-Corcoles A; Satue-Gracia E; Vila-Rovira A; de Diego-Cabanes C; Forcadell-Peris MJ; Hospital-Guardiola I; Ochoa-Gondar O; Basora-Gallisa J
BMC Public Health; 2021 Oct; 21(1):1795. PubMed ID: 34615512
[TBL] [Abstract][Full Text] [Related]
11. Impact of the COVID-19 pandemic in mortality due to respiratory diseases: A comparative analysis of 2021 and 2020 vs 2019 in Spain.
Soriano JB; Peláez A; Fernández E; Ancochea J
Med Clin (Barc); 2023 Sep; 161(5):192-198. PubMed ID: 37394353
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Respiratory Viral Infections in Deceased Persons during the COVID-19 Pandemic Season 2021-2022: A Population-Based Observational Study.
Trobajo-Sanmartín C; Navascués A; Fernández-Huerta M; Martínez-Baz I; Casado I; Ezpeleta C; Castilla J
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675876
[TBL] [Abstract][Full Text] [Related]
13. [Excess of mortality and mortality from COVID-19 and other causes of death in 2020 in Navarra, Spain].
Moreno-Iribas C; Floristán Y; Iniesta Martinez I; Aicua EA; Guevara Eslava M; Delfrade J
An Sist Sanit Navar; 2022 Dec; 45(3):. PubMed ID: 36468585
[TBL] [Abstract][Full Text] [Related]
14. Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic.
Valtuille Z; Acquaviva E; Trebossen V; Ouldali N; Bourmaud A; Sclison S; Gomez A; Revet A; Peyre H; Delorme R; Kaguelidou F
JAMA Netw Open; 2024 Apr; 7(4):e247965. PubMed ID: 38652474
[TBL] [Abstract][Full Text] [Related]
15. Clinical profile and main comorbidities of Spanish adults with Down syndrome.
Real de Asua D; Quero M; Moldenhauer F; Suarez C
Eur J Intern Med; 2015 Jul; 26(6):385-91. PubMed ID: 26025226
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome.
Belbin O; Xiao MF; Xu D; Carmona-Iragui M; Pegueroles J; Benejam B; Videla L; Fernández S; Barroeta I; Nuñez-Llaves R; Montal V; Vilaplana E; Altuna M; Clarimón J; Alcolea D; Blesa R; Lleó A; Worley PF; Fortea J
Mol Neurodegener; 2020 Aug; 15(1):46. PubMed ID: 32807227
[TBL] [Abstract][Full Text] [Related]
17. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.
Boerwinkle AH; Gordon BA; Wisch J; Flores S; Henson RL; Butt OH; McKay N; Chen CD; Benzinger TLS; Fagan AM; Handen BL; Christian BT; Head E; Mapstone M; Rafii MS; O'Bryant S; Lai F; Rosas HD; Lee JH; Silverman W; Brickman AM; Chhatwal JP; Cruchaga C; Perrin RJ; Xiong C; Hassenstab J; McDade E; Bateman RJ; Ances BM; ;
Lancet Neurol; 2023 Jan; 22(1):55-65. PubMed ID: 36517172
[TBL] [Abstract][Full Text] [Related]
18. Excess mortality among older adults institutionalized in long-term care facilities during the COVID-19 pandemic: a population-based analysis in Catalonia.
Cases L; Vela E; Santaeugènia Gonzàlez SJ; Contel JC; Carot-Sans G; Coca M; Pastor M; Carrasco I; Barbeta C; Vila A; Amil P; Plaza A; Pontes C; Piera-Jiménez J; Amblàs J
Front Public Health; 2023; 11():1208184. PubMed ID: 37732085
[TBL] [Abstract][Full Text] [Related]
19. The Emergence of COVID-19 as a Cause of Death in 2020 and its Effect on Mortality by Diseases of the Respiratory System in Spain: Trends and Their Determinants Compared to 2019.
Soriano JB; Peláez A; Fernández E; Moreno L; Ancochea J
Arch Bronconeumol; 2022 Apr; 58():13-21. PubMed ID: 35340748
[TBL] [Abstract][Full Text] [Related]
20. Views on the impact of the COVID-19 pandemic on health in people with Down syndrome from diverse backgrounds.
Santoro SL; Baker S; Blake JM; Cabrera MJ; Caughman K; Chung J; Cullen S; Gallagher M; Haugen K; Hoke-Chandler R; Krell K; Maina J; McLuckie D; Merker VL; Michael C; O'Neill K; Peña A; Pless A; Royal D; Slape M; Spinazzi NA; Torres A; Torres CG; Skotko BG
Am J Med Genet A; 2023 Aug; 191(8):2045-2056. PubMed ID: 37264986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
